SciSparc (SPRC) adds June 30, 2025 interim financials to F-3 and S-8

Rhea-AI Filing Summary

SciSparc Ltd. furnished a Form 6-K that provides its unaudited consolidated interim financial statements as of June 30, 2025, together with management’s discussion and analysis of financial condition and results of operations for the six months ended June 30, 2025.

The filing is incorporated by reference into SciSparc’s existing registration statements on Form F-3 and Form S-8, so these interim financials and related analysis become part of those offering documents from the submission date.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of November 2025

Commission file number: 001-38041

SCISPARC LTD.

(Translation of registrant’s name into English)

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

CONTENTS 

This Report of Foreign Private Issuer on Form 6-K consists of: (i) SciSparc Ltd.’s (the “Registrant”) Unaudited Consolidated Interim Financial Statements as of June 30, 2025, which is attached hereto as Exhibit 99.1; and (ii) the Registrant’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2025, which is attached hereto as Exhibit 99.2.

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Registrant’s registration statements on Form F-3 (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-233417, 333-248670 and 333-255408) and on Form S-8 (File Nos. 333-278437, 333-225773 and 333-286791) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

1

EXHIBIT INDEX

Exhibit No.
99.1		SciSparc Ltd.’s Unaudited Consolidated Interim Financial Statements as of June 30, 2025.
99.2		SciSparc Ltd.’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended June 30, 2025.
104		Cover Page Interactive Data File (embedded within Inline XBRL document).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SciSparc Ltd.
Date: November 18, 2025	By:	/s/ Oz Adler
	Name:	Oz Adler
	Title:	Chief Executive Officer and Chief Financial Officer

3

FAQ

What did SciSparc (SPRC) file on Form 6-K for November 2025?

SciSparc filed a Form 6-K furnishing unaudited consolidated interim financial statements as of June 30, 2025 and accompanying management’s discussion and analysis for the six months ended June 30, 2025, updating investors on mid‑year financial condition and operations.

Which period do SciSparc (SPRC) interim financials on this 6-K cover?

The interim financial information covers SciSparc’s unaudited consolidated financial position as of June 30, 2025 and management’s discussion and analysis of financial condition and results of operations for the six months ended June 30, 2025, effectively providing a half‑year 2025 update.

Are SciSparc (SPRC) June 30, 2025 financial statements audited?

No, the Form 6-K specifies that SciSparc’s consolidated interim financial statements as of June 30, 2025 are unaudited. Companies often provide unaudited interim data between annual reporting dates to give investors updated information on financial condition and operating performance.

How is this SciSparc (SPRC) Form 6-K used in its F-3 and S-8 registrations?

SciSparc’s Form 6-K is expressly incorporated by reference into its existing Form F-3 and Form S-8 registration statements, making the June 30, 2025 interim financial statements and MD&A part of the disclosure package supporting those securities offerings from the submission date.

Who signed SciSparc (SPRC) November 2025 Form 6-K?

The Form 6-K was signed on behalf of SciSparc Ltd. by Oz Adler, who is identified as the company’s Chief Executive Officer and Chief Financial Officer, confirming executive-level responsibility for the submitted interim financial information and related analysis.